Delivery Order SPE2DB24D1021-SPE2DB25FESYX
Award Date
1/8/25
Potential Completion Date
1/30/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,115.18 firm fixed-price delivery order is for PROQUAD VIALS (4561630029) and has an ultimate completion date of August 11, 2023.
Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,645.06 firm-fixed-price delivery order is for the procurement of PROQUAD VIALS, a medical supply. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 16, 2024. This award is a child contract under Amerisourcebergen's $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, the prime contractor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,601.99 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, is supplying these medical commodities to support military treatment programs and facilities worldwide through a large...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,247.58, is for the provision of PROQUAD VIALS, a medical product. The contract has a firm-fixed price and an ultimate completion date of December 10, 2024. It was awarded on November 18, 2024, and does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,410.80 firm-fixed-price delivery order is for PROQUAD VIALS, with a period of performance through October 28, 2024. The award is not designated as a set-aside contract.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $12,964.60 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with an ultimate completion date of December 19, 2024. The contract is not designated as a set-aside.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,039.80 fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,871.34 firm fixed-price delivery order contract is for the supply of PROQUAD VIALS, a medical product, with a completion date of January 21, 2025.
The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROQUAD VIALS. The $8,602.76 firm-fixed-price delivery order has an ultimate completion date of December 11, 2024 and is not designated as a set-aside contract.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award, valued at $3,203.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a completion date of February 6, 2024.
This award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...